Search All UT System Experts

An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure

Marc S. Penn, Farrell O. Mendelsohn, Gary L. Schaer, Warren Sherman, Maryjane Farr, Joseph Pastore, Didier Rouy, Ruth Clemens, Rahul Aras, Douglas W. Losordo

Research output: Contribution to journal › Article › peer-review

125 Scopus citations

Fingerprint

Dive into the research topics of 'An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure'. Together they form a unique fingerprint.

Medicine & Life Sciences